Sage Journals: Discover world-class research

Retricted access

Other

First published 2001-4

Clinical Development of Therapeutic Medicines: A Biopharmaceutical versus Pharmaceutical Product Comparison

Janice M. Reichert

Therapeutic Innovation & Regulatory Science

Retricted access

Other

First published 2004-7

Biotechnology Regulation: Views of the Authorities,Investors,and Product Developers in Finland

Outi Nieminen, Leena Rahkamo, Katrina Nordström

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2024-6

Productivity of the Korean Biopharmaceutical Industry: Exploring the Effect of Business Model and Open Innovation

Jaehoon Yang, Eungdo Kim

Science,Technology and Society

Retricted access

Research article

First published 2007-8

Cumulative updating of approved biopharmaceuticals

EL-Rashdy M. Redwan

Human Antibodies

Free access

Research article

First published 2015-3

Frontiers in Nonclinical Drug Development

A. M. Ryan

Veterinary Pathology

Retricted access

Other

First published 2010-3

Coping with the Regulatory Realities of Follow-on Biologics and the Nuances of US and European Regulations

Joel I. Folk, Ross A. Davidson

Therapeutic Innovation & Regulatory Science

Retricted access

Review article

First published 2012-7

Building Value Through Biomarkers

Brad Smith, Michael Stocum, Cynthia Verst [...]

Therapeutic Innovation & Regulatory Science

Open access

Research article

First published 2021-04

Considerations of the Japanese Research Working Group for the ICH S6 & Related Issues Regarding Nonclinical Safety Assessments of Oligonucleotide Therapeutics: Comparison with Those of Biopharmaceuticals

Yoko Hirabayashi, Kazushige Maki, Kiyoshi Kinoshita [...]

Nucleic Acid Therapeutics

Retricted access

Other

First published 1995-4

Research and Development,Manufacturing,and Marketing of Biopharmaceuticals: An International Comparison

Brigitta Bienz-Tadmor, Pheak Son Seo, Natalie R. Bryant [...]

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2009-2

Biosimilars: The French policy

Stéphane Schück, Nathalie Texier

International Journal of Risk & Safety in Medicine

Search results